Investigational drug · Phase 2
CYT-1010
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Acute Postoperative Pain, Dental Pain.
Phase 2Last checked: Nov 19, 2026Latest source record: Oct 29, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "CYT-1010"
First trial start
2026
Sep 25, 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "CYT-1010", any sponsor or status.
Conditions studied
As listed on its trial records.
- Acute Postoperative Pain
- Dental Pain
Approved drugs for the same conditions: Pain and anesthesia
Largest trials
Live from ClinicalTrials.gov: studies naming "CYT-1010" as an intervention, largest first.
Cytogel Pharma, LLCIndustry
NCT07905105 · 32 participants (planned) · Start Sep 25, 2026 · Primary completion Oct 2027
Drug: CYT-1010; Placebo · For: Acute Postoperative Pain; Dental Pain
Sites: Salt Lake City, Utah
Newest research
PubMed records naming it or its code names, newest first.
- Novel Opioids in the Setting of Acute Postoperative Pain: A Narrative Review.
Wang A, Murphy J, Shteynman L, et al. · Pharmaceuticals (Basel) 2023
- Dilemma of Addiction and Respiratory Depression in the Treatment of Pain: A Prototypical Endomorphin as a New Approach.
Webster L, Schmidt WK · Pain Med 2020
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.